Novel antigens.
Next-generation immunotherapies.
Our Approach
Cures of Tomorrow, Today
Developing cellular therapies faces a critical challenge: the limited availability of actionable cancer antigens. With our focus on innovative antigen discovery, we’re aiming to overcome this bottleneck and fuel the development of new immunotherapies with unparalleled precision and effectiveness.
Powerful Antigen Mining Process
A seamless integration of AI-supported bioinformatics and immunopeptidomics coupled with rigorous wet-lab target validation, designed to feed into cellular engineering process.
Explore
Expanding the pool of actionable cancer targets
Only a limited number of known tumor antigens have been successfully targeted in cancer therapy. The common challenges? Lack of tumor specificity, immunogenicity, and tumor heterogeneity. By enhancing the antigen discovery process, we’re not just identifying more cancer antigens-we’re turning them into actionable targets that drive successful therapies.
Science-Driven, Patient-Focused
Our approach is rooted in rigorous science and a deep commitment to improving patient outcomes. At Oncoceptor, we’re not just developing therapies - we are creating hope. Our cutting-edge research is driven by a passion for making a difference in the lives of those affected by cancer, one discovery at a time.
We’re Open for Collaboration
We believe that the future of cancer treatment lies in collaboration.
Whether you’re a researcher, a healthcare professional, an investor, or someone touched by cancer, we invite you to join forces with us.
Together, we can build a future where cancer is a disease of the past.